The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review-Reference-Cited by-同舟云学术

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review

Author:

Ruan Zhen¹,Yang Lisong¹,Shi Honghao¹,Yue Xiaomeng²,Wang Yao¹,Liang Miaoying³,Hu Hao¹

Affiliation:

1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China

2. Pharmacy Practice & Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA

3. International Health Management, Imperial College Business School, Imperial College London, London, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

Reference65 articles.

2. International Diabetes Federation. IDF diabetes atlas, 9th edn(2019)

3. [Accessed 2020 August 7]. Available at https://www.diabetesatlas.org/en/

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献